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Association of PS gene polymorphism and soluble P-selectin levels in atrial
ﬁbrillation thromboembolism population in Xinjiang
Ling Bai, Muhuyati
Cardiac Center, the First Afﬁliated Hospital of Xinjiang Medical
university, Urumqi, China
OBJECTIVES To investigate the association between the poly-
morphism of P choose element (p.selectin, PS) and soluble P-selectin
levels in atrial ﬁbrillation (AF) thromboembolism in Han and Uigur
population of Xinjiang.
METHODS Using ELISA method determination of plasma level of
sPs. The frequency distributions of SNP sP-selectin gene promoter
(-2123C/G) and SNP in exon region (Thr715Pro) were investigated by
PCR-restriction fragment length polymorphism and direct DNA
sequence analysis among 302 Xinjiang Uigur and 340 age- and sex-
matched Han people.
RESULTS Cases sPs exist signiﬁcant difference serum level and the
control group. The frequencies of the -2123C/G allele among the Uigur
population had no signiﬁcant differences from those of the Han
population. Thr715Pro did not show any polymorphism in the two
populations.
CONCLUSIONS The sP-selectin gene polymorphisms are associated
with serum sP-selectin levels or thromboembolic events, suggesting
that the patients with nonvalvular AF and thromboembolic events
may have genetic susceptibility.GW26-e4447
The study on microcirculatory disturbance and no-reﬂow phenomenon
mechanism after coronary artery autologous microthromboembolism in
rats
Yupeng Bai, Liqun Hu, Jie Wu, Bo Gao, Ye Gu
Department of Cardiology, Wuhan Puai Hospital, Huazhong University
of Science and Technology
OBJECTIVES To research microcirculatory disturbance and no-reﬂow
phenomenon mechanism in the model of coronary thrombotic
microembolism in rats.
METHODS 5mg dried auto-microthrombotic particulates dissolved
in 0.2 ml saline (CME group) or 0.2 ml saline (SHAM group)
was injected into temporarily clamped aorta of male Sprague-
Dawley rats. After auto-microthrombotic particulates injection,
serum c-troponin I, a von Willebrand factor (3 hours, 24 hours,
1 days, 28 days) was determined, no-ﬂow area was evaluated by
Thioﬂavin-S (3 hours), myocardial leukocyte inﬁltration (24 hours,
7days and 28days), myocardial expressions of TNF-a and IL-6
(24 hours, 7 days and 28 days) were measured by immunohisto-
chemical Analysis and Western Blot Analysis, Arteriole density (AD)
was calculated by immunohistochemical analysis. Cardiac function
was evaluated by transthoracic echocardiography and hemodynamic
measurements.
RESULTS After automicrothrombotic particulate injection, serum c-
troponin I and von Willebrand factor levels, the no-ﬂow area as
evaluated by Thioﬂavin S, myocardial leukocyte inﬁltration levels,
myocardial expressions of tumor necrosis factor and interleukin-6,
were all signiﬁcantly increased whereas cardiac function as evaluated
by echocardiography and hemodynamic measurements were signiﬁ-
cantly reduced compared with the SHAM group (P <0.05). Number of
arterioles with diameter between 10w50 mm, especially for arterioles
with diameter between 20w50 mm was signiﬁcantly lower in CME
group at 3 hours post injection(P <0.05).
CONCLUSIONS Aortic automicrothrombotic particulate injection
could induce coronary microembolism in rats, and this model could
be of value in improving the understanding of pathophysiology of
no-reﬂow phenomenon mechanism: coronary microembolism / coro-
narymicrothrombosisdendothelial damage and dysfunction / arteri-
olar spasm - no reﬂow - infarctlets - inﬂammatory reaction-myocardial
remodeling and cardiac dysfunction.GW26-e4506
Losartan cannot weaken the change of PGC-1a/NT-PGC-1a altered by
Metformin in myocardial cells
Jinghai Hua, Changhua Liu, Zhuheng Liu, Wenyan Lai, Dingli Xu
Department of Cardiology, Nanfang Hospital, Southern Medical
University, Guangzhou
OBJECTIVES It has shown that the expression of intracellular PGC-1a/
NT-PGC-1a was regulated by a variety of factors. However, it is
completely unknown whether Metformin and angiotensinII can alter
the expression of PGC-1a/NT-PGC-1a. Here we attempted to explore
the change in myocardial cells.
METHODS SD neonatal rat cardiomyocytes after isolation, cells were
seeded and corresponded to line drug stimulation, then the target
protein expression were detected with Immunoﬂuorescence and
Western blotting.
RESULTS Metformin and angiotensinII can enhance the expression of
PGC-1a/NT-PGC-1a in myocardial cells. Whereas, Losartan cannot
weaken the change altered by metformin, but can abirritate the effect
mediated by angiotensin II. Additionally, its expression also could be
inﬂuenced by other factors, such as seeded in low glucose or serum-
free state, low temperature and the prolongation of the culture time.
CONCLUSIONS The mechanism of metformin augmenting the
expression of PGC-1a/NT-PGC-1a is not RAAS pathways but others in
myocardial cells.
GW26-e0208
Naturally occurring multiple-modiﬁed low density lipoprotein (LDL)
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OBJECTIVES Electronegative LDL, small dense LDL, and desialylated
LDL circulating in the blood of patients were obtained by different
methods. Naturally, the question arises what are the similarities and
differences between these forms of LDL modiﬁcation. We believe that
multiple modiﬁed LDL particle (small, dense, electronegative, desia-
lylated, etc.) occurs in blood.
METHODS Ex vivo experiments have revealed mechanisms of multi-
ple modiﬁcation of LDL in the blood. Fraction of native LDL was iso-
lated from blood plasma of healthy subjects. Blood serum of patients
with assessed atherosclerosis was also obtained. LDL and serum were
mixed and incubated for various periods at 37C.
RESULTS After 1 hour incubation of native LDL with atherosclerotic
serum desialylated LDL appears. After 3 hours, LDL becomes able to
cause accumulation of cholesterol in cultured cells. After 6 hours, LDL
demonstrates reduction of neutral lipids and phospholipids as well as
reduction in its size. After 36 hours, an increase in the electronega-
tivity of the lipoprotein particle is detected. After 48-72 hours, loss of
a-tocopherol, increase of susceptibility to oxidation, and accumula-
tion of lipid peroxidation products in LDL are observed. Thus, mul-
tiple modiﬁcation of LDL is a cascade of sequential changes in
lipoprotein particle, namely: desialylation, loss of lipids, size reduc-
tion, increase of electronegative charge, lipid peroxidation in LDL.
Desialylation of LDL particle is one of the ﬁrst or primary events of
atherogenic modiﬁcation. We have established that the reason of LDL
desialylation is trans-sialidase. We found trans-sialidase activity in
the blood of patients with atherosclerosis and other cardiovascular
diseases. We have shown that human neuraminidases 2 and 4 possess
trans-sialidase activity. On the other hand, selective inhibitors of viral
sialidases suppress trans-sialidase activity in the blood of athero-
sclerotic patients.
CONCLUSIONS Thus, trans-sialidase causing atherogenic desialyla-
tion of LDL may be of both endogenous and exogenous origin. Sup-
ported by Russian Ministry of Education and Science (Project
RFMEFI61614X0010).
